Professor Satoshi Ōmura
Satoshi Ōmura is a world leader in Bioorganic Chemistry, with pioneering and unmatched expertise and success in discovering bioactive chemicals derived from naturally-occurring microorganisms. He is also recognized as a leading expert in macrolide antibiotics.
During his 40-year career, Professor Ōmura has devised many novel methods for isolating, culturing and screening microorganisms, discovering more than 470 compounds, many of them unique. Some of his discoveries are seen as the forerunners for the statins, novel anticancer compounds and world-leading drugs in animal and human health. His creation of hybrid antibiotics opened up a completely new field of highly-promising research.
Paramount among the compounds he unearthed are the avermectins/ivermectin, discovered and developed through a collaborative research program he established with Merck & Co. Inc. (USA). Ivermectin is one of the world's most important animal and human medicines ever produced, one of the foremost public health interventions ever in the developing world, and seen to rival penicillin for its beneficial impact on global health - with over 300 million people using the compound annually. For his leading role in the discovery of the avermectins, he has been awarded the highly prestigious Gairdner Global Health Award (2014).
Professor Ōmura is currently Distinguished Emeritus Professor at Kitasato University (Japan), Max Tishler Professor of Chemistry at Wesleyan University (USA) and President of Joshibi University of Art and Design (Japan).
February, 16. 2017Biography page (calligraphy) updated.
September, 11. 2015Biography page, Biography (Japanese) page, and Publication List (2010-current) updated.
March, 27. 2014Home page, Biography page, Biography (Japanese) page, Molecules page, Publication page, and Ivermectin page updated.
December, 3. 2013Biography page updated.
November, 6. 2013Biography page (Japanese) updated.